Novel inhalation formulation of colistin and combination therapy against Gram-negative 'superbugs'.

  • Chan, Hak-Kim (Primary Chief Investigator (PCI))
  • Zhou, Qi (Chief Investigator (CI))
  • Li, Jian (Chief Investigator (CI))
  • Fouras, Andreas, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/1431/12/16

Funding

  • National Health & Medical Research Council (NHMRC): AUD303,981.00